Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: The T-cell response to SARS-CoV- 2 vaccination persists beyond six months in rheumatoid arthritis patients treated with rituximab

Fig. 2

Global spike-specific T-cell response in the study cohort. CD4+ T-cell (A) or CD8 + T-cell (B) global activation parameters in RA patients treated (RA RTX +, n = 51) or not treated (RA no RTX, n = 24) with rituximab. Green symbols (circles in the RA without RTX group and triangles in the RA RTX + group) refer to vaccinated patients who had no history of COVID- 19. Red symbols (circles in the RA non-RTX group and triangles in the RA RTX + group) refer to vaccinated patients who had a history of COVID- 19

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us